Report: Anti-smoking legislation could generate $700 million a year for cancer research |
![]() |
![]() |
By Staff and Wire Reports |
Monday, 19 March 2012 10:47 |
![]() According to the publication, the measure is opposed by tobacco companies as a “$735 million tax hike” that is “flawed and poorly drafted,” but proponents including patient advocacy groups and universities argue it will bring significant health and economic benefits to the Golden State. We spoke to Jim Knox, vice president of legislative advocacy for the American Cancer Society and a member of the Yes on 29 board, about the proposition, what passage could mean to cancer research, and what it would do for California’s status as a center for biomedical innovation. The March Review/Preview Issue of The Burrill Report is now available for free download. "Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'. Add this page to your favorite Social Bookmarking websites ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |